Raymond James Financial’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Sell
50,789
-10,805
-18% -$58K ﹤0.01% 4931
2026
Q1
$333K Sell
61,594
-21,945
-26% -$131K ﹤0.01% 4603
2025
Q4
$581K Sell
83,539
-24,082
-22% -$158K ﹤0.01% 4161
2025
Q3
$694K Buy
107,621
+29,783
+38% +$204K ﹤0.01% 3925
2025
Q2
$518K Buy
77,838
+53,186
+216% +$273K ﹤0.01% 3988
2025
Q1
$159K Buy
24,652
+2,321
+10% +$16.7K ﹤0.01% 4473
2024
Q4
$180K Buy
+22,331
New +$184K ﹤0.01% 4428

Other funds holding BHC

Raymond James Financial's BHC Position: Q2 2026 in Review

Raymond James Financial reduced its Bausch Health (BHC) stake by 18% in Q2 2026, selling an estimated $58K and leaving 50,789 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #4931.

Raymond James Financial first reported a position in BHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $694K in Q3 2025. 222 funds tracked by Wall St. Rank hold BHC as of Q2 2026.

  • Raymond James Financial held 50,789 shares of Bausch Health worth $250K as of Q2 2026.
  • Raymond James Financial sold 10,805 Bausch Health shares in Q2 2026, an estimated $58K.
  • Bausch Health made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #4931 holding.
  • Raymond James Financial first reported a position in Bausch Health in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Bausch Health position peaked at $694K in Q3 2025.
  • 222 funds tracked by Wall St. Rank held Bausch Health as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.